Chuang Yi Biotech co., ltd.

TPEX:6566 Stock Report

Market Cap: NT$176.5m

Chuang Yi Biotech Balance Sheet Health

Financial Health criteria checks 6/6

Chuang Yi Biotech has a total shareholder equity of NT$134.8M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$185.4M and NT$50.6M respectively.

Key information

0%

Debt to equity ratio

NT$0

Debt

Interest coverage ration/a
CashNT$39.70m
EquityNT$134.78m
Total liabilitiesNT$50.59m
Total assetsNT$185.37m

Recent financial health updates

Recent updates

Why Chuang Yi Biotech's (GTSM:6566) Earnings Are Weaker Than They Seem

Apr 29
Why Chuang Yi Biotech's (GTSM:6566) Earnings Are Weaker Than They Seem

Is Chuang Yi Biotech (GTSM:6566) Using Too Much Debt?

Dec 23
Is Chuang Yi Biotech (GTSM:6566) Using Too Much Debt?

Financial Position Analysis

Short Term Liabilities: 6566's short term assets (NT$122.3M) exceed its short term liabilities (NT$46.7M).

Long Term Liabilities: 6566's short term assets (NT$122.3M) exceed its long term liabilities (NT$3.8M).


Debt to Equity History and Analysis

Debt Level: 6566 is debt free.

Reducing Debt: 6566 has no debt compared to 5 years ago when its debt to equity ratio was 0.4%.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 6566 has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: 6566 has sufficient cash runway for 1.2 years if free cash flow continues to grow at historical rates of 23.4% each year.


Discover healthy companies